Zuil 2 ondernemend
(Voorpagina foto HU logo, z.d.)
2021_GHU-V2CURSUS7-20_2_V, Zorg verlenen bij circulatiestoornissen.
Zuil: Ondernemend. Huidproblematiek bij Diabetes Mellitus, Diabetische ulcera, Zorg
op afstand.
Student naam:
Studentenummer:
Tutor:
Hogeschool Utrecht
2021/2022
1
,Inhoudsopgave
Aanbeveling............................................................................................................................................4
Klinisch scenario.....................................................................................................................................4
PICO........................................................................................................................................................5
Zoekstrategie..........................................................................................................................................5
Databank................................................................................................................................................5
Filters......................................................................................................................................................5
Zoektermen............................................................................................................................................5
Hits.........................................................................................................................................................5
Bruikbare hits.........................................................................................................................................5
Cinahl......................................................................................................................................................5
2011-2021..............................................................................................................................................5
Diabetic foot ulcer or diabetic ulcer or diabetic wound.........................................................................5
5,574.......................................................................................................................................................5
................................................................................................................................................................5
................................................................................................................................................................5
Cinahl......................................................................................................................................................5
2011-2021..............................................................................................................................................5
Telemedicine or telehealth or telemonitoring........................................................................................5
23,375.....................................................................................................................................................5
Cinahl......................................................................................................................................................5
2011-2021..............................................................................................................................................5
Effectiveness or advantages or benifits or success.................................................................................5
217,270...................................................................................................................................................5
Cinahl......................................................................................................................................................5
2011-2021..............................................................................................................................................5
(S1 diabetic foot ulcer OR diabetic ulcer OR diabetic wound)................................................................5
(S2 telemedicine OR telehealth OR telemonitoring)..............................................................................6
(S3 effectiveness OR advantages OR benifits OR succes)........................................................................6
S1 and S2 and S3.....................................................................................................................................6
10............................................................................................................................................................5
5..............................................................................................................................................................5
................................................................................................................................................................6
14............................................................................................................................................................6
2
, Telehealth and telemedicine applications for the diabetic foot: A systematic review...........................7
Telemedicine in Diabetic Foot Care: A Systematic Literature Review of Interventions and Meta-
analysis of Controlled Trials....................................................................................................................7
Kritische beoordeling..............................................................................................................................8
Design studie..........................................................................................................................................8
................................................................................................................................................................8
Populatie................................................................................................................................................8
Interventie..............................................................................................................................................8
Meetinstrumenten en uitkomstmaat.....................................................................................................9
Resultaten..............................................................................................................................................9
Telehealth and telemedicine applications for the diabetic foot: A systematic review.........................11
Design studie........................................................................................................................................11
Populatie..............................................................................................................................................11
Interventie............................................................................................................................................11
Meetinstrumenten en uitkomstmaat...................................................................................................12
Resultaten............................................................................................................................................12
Telemedicine in Diabetic Foot Care: A Systematic Literature Review of Interventions and Meta-
analysis of Controlled Trials..................................................................................................................17
Design studie........................................................................................................................................17
..............................................................................................................................................................17
Populatie..............................................................................................................................................17
Interventie/ controlegroep...................................................................................................................18
Meetinstrumenten en uitkomstmaat...................................................................................................18
Resultaten............................................................................................................................................19
Interne en externe validiteit.............................................................................................................21
Kritische reflectie..............................................................................................................................21
Conclusie..............................................................................................................................................22
Toepassing in praktijk...........................................................................................................................22
Algemene informatie............................................................................................................................22
Literatuurlijst........................................................................................................................................22
3